Does TOPOTECAN Cause Disease progression? 207 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 207 reports of Disease progression have been filed in association with TOPOTECAN (HYCAMTIN). This represents 5.9% of all adverse event reports for TOPOTECAN.
207
Reports of Disease progression with TOPOTECAN
5.9%
of all TOPOTECAN reports
77
Deaths
30
Hospitalizations
How Dangerous Is Disease progression From TOPOTECAN?
Of the 207 reports, 77 (37.2%) resulted in death, 30 (14.5%) required hospitalization, and 3 (1.4%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOPOTECAN. However, 207 reports have been filed with the FAERS database.
What Other Side Effects Does TOPOTECAN Cause?
Febrile neutropenia (425)
Off label use (390)
Death (332)
Product use in unapproved indication (323)
Neutropenia (255)
Pyrexia (252)
Anaemia (242)
Malignant neoplasm progression (238)
Drug ineffective (216)
Thrombocytopenia (207)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which TOPOTECAN Alternatives Have Lower Disease progression Risk?
TOPOTECAN vs TOPOTECAN\TOPOTECAN
TOPOTECAN vs TOPROL
TOPOTECAN vs TOREMIFENE
TOPOTECAN vs TORIPALIMAB
TOPOTECAN vs TORSEMIDE